Blood Test News and Research

RSS

Researchers lay foundation for future lung cancer detection test

Scientists working with Professor Dr. Joachim L. Schultze have identified over 480 molecules whose concentration in the blood changes when a person develops lung cancer. These molecules are present in the blood cells either in increased or decreased quantities. "In lung cancer patients, typical patterns which can be detected with a measuring program thus emerge", explains Prof. Schultze.

17 May 2011

Life expectancy blood test not popular with experts

According to scientists and medical ethicist there are hidden dangers of a new blood test for determining how fast someone is ageing. The test costs £435 test and is due to go on sale to the general public in Britain later this year, measures the length of a person's telomeres, the structures on the tips of the chromosomes which get progressively shorter with age. Short telomeres are linked with age-related diseases and premature death.

17 May 2011

Gene variant linked to infertility in women

A variation in a gene involved in regulating cholesterol in the bloodstream also appears to affect progesterone production in women, making it a likely culprit in a substantial number of cases of their infertility, a new study from Johns Hopkins researchers suggests.

16 May 2011

Bonn researchers to develop new blood test for lung cancer diagnosis

A person's blood reveals whether he or she has lung cancer: this has been demonstrated by researchers at the University of Bonn. In collaboration with colleagues at the Cologne University Hospital, they are developing a blood test for smokers which could save human lives in the future, since the earlier a lung tumor is detected, the better the chances of survival are.

16 May 2011

Researchers identify miRNA in blood serum of lung cancer patients

Researchers have identified characteristic patterns of molecules called microRNA in the blood of people with lung cancer that might reveal both the presence and aggressiveness of the disease, and perhaps who is at risk of developing it.

13 May 2011

Study: OVA1 blood test can accurately predict ovarian cancer in women with pelvic masses

A study published online ahead of print in the June 2011 edition of Obstetrics & Gynecology demonstrated that American College of Obstetrics and Gynecology guidelines for determining the likelihood that an ovarian mass is cancerous prior to surgery would accurately identify more women with ovarian cancer if the OVA1 blood test were used in place of the currently recommended CA 125 blood test.

From Quest Diagnostics 13 May 2011

Genetic test to identify women at higher risk of breast cancer could reduce risks associated with screening

Calculating individual genetic cancer risk and taking age into account could mean fewer women would need to be screened for breast cancer, according to research published in the British Journal of Cancer1.

11 May 2011

U.S. veterans over 70 and older can benefit from current colon cancer screening methods

A new study of U.S. veterans ages 70 and older finds that the healthiest get the most benefit from current colon cancer screening methods. However, for many less healthy veterans the burdens of screening may outweigh the benefits.

10 May 2011

Epigenomics presents Septin9 blood test study data in colorectal cancer at DDW 2011

Epigenomics AG, the cancer molecular diagnostics company, reports that Dr. Uri Ladabaum, Associate Professor in the Department of Gastroenterology and Hepatology at the School of Medicine of Stanford University, has presented the results of a health economic analysis of potential future colorectal cancer screening with Septin9 blood tests at the ongoing Digestive Disease Week 2011.

9 May 2011

Epigenomics, Life Technologies enter supply agreement for second-generation colorectal cancer blood test

Epigenomics AG, the cancer molecular diagnosis company, today announced the signing of a supply agreement with Life Technologies Corporation, a global provider of innovative life science solutions.

7 May 2011

Despite expanded Medicare coverage racial disparities continue in colorectal cancer screening

Despite expanded Medicare coverage for colorectal cancer screening tests, lower rates still exist among blacks and Hispanics compared to other ethnic groups, according to research published in Cancer, Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

6 May 2011

Scientists use new technologies to identify genetic cause of Kufs disease

Scientists from the Walter and Eliza Hall Institute and the University of Melbourne have used innovative new technologies to identify the gene responsible for a rare but fatal hereditary brain disorder. The discovery will make it possible to diagnose the disease through a blood test rather than a brain biopsy.

6 May 2011

New non-invasive blood test may detect early stage Alzheimer's

A new blood test that will diagnose Alzheimer's disease may soon hit the market, thanks to an innovative study from the Research Institute of the McGill University Health Centre.

4 May 2011

Free medical clinic at Tacoma Dome to serve more patients

This Saturday's massive free medical clinic for the uninsured at the Tacoma Dome will add 250 more patient appointments as a result of an outpouring of support from medical and non-medical volunteers.

30 Apr 2011

Simple blood test can diagnose early Parkinson's disease

In Parkinson's disease, the human body generates antibodies to combat the amyloid-producing protein alpha synuclein early in the course of the disease. A simple blood test that measures these antibodies can facilitate early diagnosis of the disorder, writes Ludmilla Morozova-Roche and her associates at Umeå University in Sweden in the latest issue of the journal PLoS One.

28 Apr 2011

TB screening misses immigrants: Study

According to a latest study published in The Lancet, one in five new immigrants to the UK from the Indian subcontinent, and almost a third from sub-Saharan Africa, carried latent tuberculosis (TB).

28 Apr 2011

New screening marker can detect pancreatic cancer

Researchers at the University of Michigan Comprehensive Cancer Center have identified a protein that shows distinct changes in structure between pancreatic cancer, non-cancerous diseases and normal blood serum. The protein also changes from early stage pancreatic cancer to advanced disease.

28 Apr 2011

Bayer's oral contraceptives may increase risk of blood clots, stroke or heart attack

Bayer HealthCare Pharmaceuticals, Inc. is aware of two studies published today in The British Medical Journal, ONLINE FIRST.

25 Apr 2011

KellBenx secures $2.5 million from initial funding round

KellBenx, a biotechnology company focused on the development of non-invasive prenatal diagnosis (NIPD) of genetic and inherited disorders, announced today that it has secured an initial funding round of $2.5 million from four investors – three biotechnology venture capital groups and one angel investor. The round will finance a clinical trial and laboratory testing of a new, minimally invasive blood test designed to identify risks to pregnancy ranging from pre-term birth to genetic conditions.

21 Apr 2011

Sialix announces blood test results for early detection and treatment of breast cancer

Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.

20 Apr 2011

Blood Test News and Research

Researchers lay foundation for future lung cancer detection test

Life expectancy blood test not popular with experts

Gene variant linked to infertility in women

Bonn researchers to develop new blood test for lung cancer diagnosis

Researchers identify miRNA in blood serum of lung cancer patients

Study: OVA1 blood test can accurately predict ovarian cancer in women with pelvic masses

Genetic test to identify women at higher risk of breast cancer could reduce risks associated with screening

U.S. veterans over 70 and older can benefit from current colon cancer screening methods

Epigenomics presents Septin9 blood test study data in colorectal cancer at DDW 2011

Epigenomics, Life Technologies enter supply agreement for second-generation colorectal cancer blood test

Despite expanded Medicare coverage racial disparities continue in colorectal cancer screening

Scientists use new technologies to identify genetic cause of Kufs disease

New non-invasive blood test may detect early stage Alzheimer's

Free medical clinic at Tacoma Dome to serve more patients

Simple blood test can diagnose early Parkinson's disease

TB screening misses immigrants: Study

New screening marker can detect pancreatic cancer

Bayer's oral contraceptives may increase risk of blood clots, stroke or heart attack

KellBenx secures $2.5 million from initial funding round

Sialix announces blood test results for early detection and treatment of breast cancer

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News